☆ 4.7 Editorial Material

The Potential Future of the COVID-19 Pandemic Will SARS-CoV-2 Become a Recurrent Seasonal Infection?

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Correction Psychology, Biological

Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA (Feb, 10.1038/s41562-021-01056-1, 2021)

Sahil Loomba et al.

NATURE HUMAN BEHAVIOUR (2021)

Add to Collection

Article Multidisciplinary Sciences

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Chadi M. Saad-Roy et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Herd Immunity'': A Rough Guide

Paul Fine et al.

CLINICAL INFECTIOUS DISEASES (2011)

Add to Collection

The Potential Future of the COVID-19 Pandemic Will SARS-CoV-2 Become a Recurrent Seasonal Infection?

Related references

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA (Feb, 10.1038/s41562-021-01056-1, 2021)

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Herd Immunity'': A Rough Guide

Export Citation

Share Paper